SCHEMBL25501114

SCHEMBL25501114

CC1(C)OCC(Cn2ccc(N)nc2=O)CO1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 4/20 0.49
▸ PDE3A Q14432 3/20 0.37
▸ LMNA P02545 3/20 0.37
▸ CACNA1F O60840 2/20 0.37
▸ ALB P02768 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ CACNA1D Q01668 2/20 0.37
▸ CACNA1S Q13698 2/20 0.37
▸ CACNA1C Q13936 2/20 0.37
▸ P2RX3 P56373 7/20 0.37
▸ PDE4D Q08499 1/20 0.36
▸ SLC29A1 Q99808 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ MDM2 Q00987 1/20 0.36
▸ NCOA1 Q15788 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ SLC22A6 Q4U2R8 1/20 0.36
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11720724 0.80 FGFR1 (0.50) FGFR1PDE3ALMNACACNA1FALB
SCHEMBL27292735 0.77 FGFR1 (0.69) FGFR1PDE3ALMNACACNA1FALB
SCHEMBL30364544 0.77 FGFR1 (0.45) FGFR1PDE3ALMNACACNA1FALB
SCHEMBL26231021 0.72 ABL1 (0.50) LMNAMAPTALDH1A1NPSR1
SCHEMBL30364620 0.72 FGFR1 (0.46) FGFR1PDE3ALMNACACNA1FALB
SCHEMBL30364477 0.72 FGFR1 (0.46) FGFR1PDE3ALMNACACNA1FALB
SCHEMBL1892698 0.71 FGFR1 (0.44) FGFR1PDE3ALMNACACNA1FALB
SCHEMBL16446911 0.70 FGFR1 (0.47) FGFR1PDE3ALMNACACNA1FALB
SCHEMBL20509969 0.69 FGFR1 (0.59) FGFR1PDE3ALMNACACNA1FALB
SCHEMBL20919715 0.69 FGFR1 (0.46) FGFR1PDE3ALMNACACNA1FALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4328310-A1 SIRNA TARGETING 17B-HYDROXYSTEROID DEHYDROGENASE TYPE 13 AND SIRNA CONJUGATE Tuojie Biotech (Shanghai) Co., Ltd. (CN) 2024-02-28 — — EP disclosed
US-20230287418-A1 MODIFIED SIRNA WITH REDUCED OFF-TARGET ACTIVITY TUOJIE BIOTECH(SHANGHAI) CO., LTD. (CN) 2023-09-14 — — US disclosed
US-20230287418-A1 MODIFIED SIRNA WITH REDUCED OFF-TARGET ACTIVITY TUOJIE BIOTECH(SHANGHAI) CO., LTD. (CN) 2023-09-14 — — US disclosed
WO-2023109932-A1 DSRNA AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海拓界生物医药科技有限公司 2023-06-22 — — WO disclosed
WO-2023109938-A1 DSRNA, PREPARATION METHOD THEREFOR AND USE THEREOF 上海拓界生物医药科技有限公司 2023-06-22 — — WO disclosed
WO-2023109945-A1 DSRNA, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海拓界生物医药科技有限公司 2023-06-22 — — WO disclosed
WO-2023109935-A1 DSRNA, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海拓界生物医药科技有限公司 2023-06-22 — — WO disclosed
WO-2023109940-A1 LPA-TARGETING SIRNA AND CONJUGATE 上海拓界生物医药科技有限公司 2023-06-22 — — WO disclosed
EP-4194553-A1 MODIFIED SIRNA WITH REDUCED OFF-TARGET ACTIVITY Tuojie Biotech (Shanghai) Co., Ltd. (CN) 2023-06-14 — — EP disclosed
WO-2023088427-A1 SIRNA TARGETING ANGIOTENSINOGEN AND PHARMACEUTICAL USE OF SIRNA 上海拓界生物医药科技有限公司 2023-05-25 — — WO disclosed
Send feedback